Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-contact coal tar versus placebo during UVB therapy for plaque psoriasis
NL-OMON32958Phase 4Withdrawn
- Sponsor
- Amphia Ziekenhuis
- Start
- May 2009
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in psoriasis and plaque psoriasis comparing Coal tar + UVB therapy with Placebo + UVB therapy (2 arms). Primary endpoint: Number of UVB sessions until clearance of psoriatic lesions. Planned start May 2009; status: withdrawn.
02
Drugs
coal tar
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on NL-OMON32958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32958.